LipiFlow Thermal Pulsation System

Johnson & Johnson

Sensor-controlled delivery of heat and pressure to liquify and evacuate meibomian gland contents

At-a-Glance
  • Computer-controlled, simultaneous application of heat and pressure
  • After an initial anesthetic drop, no drugs are required for the procedure
  • The LipiFlow System safely delivers therapeutic energies to the meibomian glands where obstructed meibum is liquefied and pushed up and out of the gland orifices
  • Insulated, contoured design of the Activator vaults the cornea to protects the delicate structures of the eye
  • Heat and pressure are regulated with redundant sensors
LipiFlow Calculator Thmbnail
Reimbursement Calculator: LipiFlow and LipiScan

Estimate potential revenue based on instrument costs, reimbursment rates, and your practice's patient volume.

Find your Revenue Potential

Description

The LipiFlow Thermal Pulsation System is a device for in-office treatment of dry eye disease (DED) associated with meibomian gland dysfunction (MGD). It consists of a console, reusable cable and a single-use sterile device known as the Activator II. The Activator cradles the upper and lower eyelid as therapeutic heat and proximal-to-distal peristaltic pressure is applied to the meibomian glands.

LipiFlow mechanism of action

The Science Behind LipiFlow

The sophistication of the devices centers around the Vector Thermal Pulse Technology (VTP) which analyzes feedback from sensors on the Activator to maintain consistent heat application and a phased pressure profile with adaptive force equalization.

  • Vectored

    The vaulted interior shield of the Activator protects the cornea while multi-point sensors monitor and regulate heat and pressure throughout the treatment. A maximum therapeutic temperature of 43 degrees Celsius is applied directly to the inner eyelid where the glands are located, while protecting the eyelid or delicate structures of the globe.

  • Thermal

    Proprietary heating technology ensures precise temperature regulation with continuous feedback and consistent heat application to the meibomian glands. The insulated and vaulted design of the Activator protects the cornea from unsafe temperatures.

  • Pulse

    Intelligent pressure feedback loop sends pulsed sequences to expel blockages and stagnant material from the gland. The custom pressure sequence maximizes gland clearing while device design protects the eye from unnecessary intraocular pressure.

The Lipiflow Activiator II

Inflation Technology

Pressure Sensors in the console ensure the application of safe levels of pressure.


Lid warmer

Multiple redundant sensors within the lid warmer protect against unsafe temperatures.



Vaulted Cornea Shield

Insulation protects the cornea from exceeding a safe 39.5 degrees Celsius, while an intelligent pressure feedback loop sends pulsed sequences to expel blockages and stagnant material from the gland. The vaulted design protects the delicate structures of the eye from both heat and pressure.


Inflation Technology

Pressure Sensors in the console ensure the application of safe levels of pressure.

Lid warmer

Multiple redundant sensors within the lid warmer protect against unsafe temperatures.

Vaulted Cornea Shield

Insulation protects the cornea from exceeding a safe 39.5 degrees Celsius, while an intelligent pressure feedback loop sends pulsed sequences to expel blockages and stagnant material from the gland. The vaulted design protects the delicate structures of the eye from both heat and pressure.

Details

FDA

Yes

CE Mark

Yes

From Your Peers

I offer BlephEx and LipiFlow treatments, usually together, especially to patients with OSD who are considering premium cataract surgery or LVC.

CRSToday, March 2018

Marguerite McDonald, MD, FACS

READ ARTICLE »

I think it is a package treatment today: meibomian probing if the glands are totally blocked, meibomian expression, LipiFlow, and IPL. The combination works.

CRSToday, January 2018

Roger Zaldivar, MD, MBA

READ ARTICLE »

For patients with more advanced disease, we may stack any single or combination of the following options: cyclosporine (Restasis; Allergan), lifitegrast (Xiidra; Shire), LipiFlow (Johnson & Johnson Vision), or a short course of loteprednol etabonate ophthalmic gel (Lotemax; Bausch + Lomb).

CollaborativeEYE, January 2018

Elizabeth Yeu, MD

READ ARTICLE »

User Ratings + Reviews

Average User Rating

5 Stars
80% Complete
4 Stars
80% Complete
3 Stars
80% Complete
2 Stars
80% Complete
1 Star
80% Complete

LipiFlow targets the Meibomian glands. I appreciate the years of science, engineering and proven results that corroborate the effectiveness of LipiFlow in improving patient's signs and symptoms of MGD.

Stephen S L., MD, United States

Show More